+44.0%
TSN vs THC
+1,460.6%
-1,416.6%
-52.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.6% | -2.9% | +2.2% | -0.2% |
| 7D | +7.8% | -8.1% | +15.9% | +9.1% |
| 30D | +15.3% | -3.2% | +18.5% | +15.8% |
| 3M | +10.1% | -1.8% | +11.9% | +10.2% |
| 6M | -1.8% | +37.7% | -39.5% | -6.8% |
| YTD | +11.8% | +32.6% | -20.9% | +5.9% |
| 1Y | +24.6% | +35.7% | -11.1% | +17.6% |
| 3Y | +45.4% | +313.5% | -268.1% | +12.6% |
| 5Y | -8.1% | +240.3% | -248.5% | -29.4% |
| All | +44.0% | +1,460.6% | -1,416.6% | -21.0% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling